echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Clin Exp Allergy: Is the development of eczema still related to gender?

    Clin Exp Allergy: Is the development of eczema still related to gender?

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Eczema, also known as atopic dermatitis and atopic eczema, is a common chronic inflammatory skin disease that is usually accompanied by a relapse-remission process
    .


    It is estimated that as many as 20% of children and 10% of adults are affected by eczema


    child

    There is consensus that most cases of eczema occur in early childhood at the age of 7, 9, and 10 years; however, little is known about the long-term natural history of this disease
    .


    It is generally believed that most early childhood cases are cured in childhood, and very few cases develop during adolescence and adulthood.


    consensus

    The investigators of the Isle of Wight Birth Cohort (IOWBC) study conducted 6 follow-up visits over a period of 26 years.
    They were 1, 2, 4, 10, 18, and 26 years of age.
    Eczema was evaluated at each follow-up
    .


    Using data from IOWBC, the purpose of this study is to investigate the natural development process of eczema from infancy to early adulthood to determine the different development trajectories describing the disease over time


    Methods: The Isle of Wight birth cohort (n=1,456) was prospectively evaluated at birth, 1 year, 2 years, 4 years, 10 years, 18 years, and 26 years
    .


    In all assessments, eczema was defined as chronic or chronic recurrent pruritic dermatitis lasting more than 6 weeks, with a characteristic shape and distribution in the past 12 months


    Results: In men and women, the development trajectory of eczema is as follows: unaffected/temporary (male: 77.
    7% vs.
    female: 73.
    0%), moderate onset and late regression (male: 7.
    8% vs.
    female: 4.
    4%), Late onset (male: 5.
    2% vs.
    female: 9.
    5%), and early onset persistence (male: 9.
    3% vs.
    female: 5.
    4%)
    .


    Among women, another trajectory was found: early-onset premature withdrawal (7.


    In short, we describe the natural process and development trajectory of eczema from infants to early adulthood
    .


    Our results indicate that men and women may experience different eczema courses and different risk factors


    FLG LOF variants and paternal eczema are associated with a higher risk of early onset trajectories in men, while maternal eczema and high birth weight are associated with early onset trajectories in women


    Literature source: Ziyab AH, Mukherjee N, Zhang H, Sex-specific developmental trajectories of eczema from infancy to age 26 years: a birth cohort study, Clin Exp Allergy 2021 Dec 01;

    Ziyab AH, Mukherjee N, Zhang H,Sex-specific developmental trajectories of eczema from infancy to age 26 years: a birth cohort study, Clin Exp Allergy 2021 Dec 01;

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.